• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过电穿孔对人多发性骨髓瘤细胞进行高效瞬时转染——一项评估

Efficient transient transfection of human multiple myeloma cells by electroporation--an appraisal.

作者信息

Steinbrunn Torsten, Chatterjee Manik, Bargou Ralf C, Stühmer Thorsten

机构信息

Department of Internal Medicine II, Division of Hematology and Oncology, University Hospital of Würzburg, Würzburg, Germany.

Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany.

出版信息

PLoS One. 2014 Jun 5;9(6):e97443. doi: 10.1371/journal.pone.0097443. eCollection 2014.

DOI:10.1371/journal.pone.0097443
PMID:24901949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4047019/
Abstract

Cell lines represent the everyday workhorses for in vitro research on multiple myeloma (MM) and are regularly employed in all aspects of molecular and pharmacological investigations. Although loss-of-function studies using RNA interference in MM cell lines depend on successful knockdown, no well-established and widely applied protocol for efficient transient transfection has so far emerged. Here, we provide an appraisal of electroporation as a means to introduce either short-hairpin RNA expression vectors or synthesised siRNAs into MM cells. We found that electroporation using siRNAs was much more efficient than previously anticipated on the basis of transfection efficiencies deduced from EGFP-expression off protein expression vectors. Such knowledge can even confidently be exploited in "hard-to-transfect" MM cell lines to generate large numbers of transient knockdown phenotype MM cells. In addition, special attention was given to developing a protocol that provides easy implementation, good reproducibility and manageable experimental costs.

摘要

细胞系是多发性骨髓瘤(MM)体外研究的常用工具,常用于分子和药理学研究的各个方面。尽管在MM细胞系中使用RNA干扰进行功能丧失研究依赖于成功的敲低,但目前尚未出现成熟且广泛应用的高效瞬时转染方案。在此,我们评估了电穿孔作为将短发夹RNA表达载体或合成的小干扰RNA(siRNA)导入MM细胞的一种方法。我们发现,基于从蛋白质表达载体的EGFP表达推导的转染效率,使用siRNA进行电穿孔比之前预期的效率要高得多。这些知识甚至可以可靠地应用于“难转染”的MM细胞系,以产生大量具有瞬时敲低表型的MM细胞。此外,我们特别关注开发一种易于实施、具有良好可重复性且实验成本可控的方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/b3317987edd2/pone.0097443.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/2ddd47cdc939/pone.0097443.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/3e6999ae2dec/pone.0097443.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/9447d6fc36bf/pone.0097443.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/e49e52e3e4ed/pone.0097443.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/9a11748a82ba/pone.0097443.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/b3317987edd2/pone.0097443.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/2ddd47cdc939/pone.0097443.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/3e6999ae2dec/pone.0097443.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/9447d6fc36bf/pone.0097443.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/e49e52e3e4ed/pone.0097443.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/9a11748a82ba/pone.0097443.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9235/4047019/b3317987edd2/pone.0097443.g006.jpg

相似文献

1
Efficient transient transfection of human multiple myeloma cells by electroporation--an appraisal.通过电穿孔对人多发性骨髓瘤细胞进行高效瞬时转染——一项评估
PLoS One. 2014 Jun 5;9(6):e97443. doi: 10.1371/journal.pone.0097443. eCollection 2014.
2
Efficient, high-throughput transfection of human embryonic stem cells.高效、高通量转染人胚胎干细胞。
Stem Cell Res Ther. 2010 Jul 26;1(3):23. doi: 10.1186/scrt23.
3
Effective plasmid DNA and small interfering RNA delivery to diseased human brain microvascular endothelial cells.将有效质粒DNA和小干扰RNA递送至患病的人脑微血管内皮细胞。
J Mol Microbiol Biotechnol. 2012;22(4):245-57. doi: 10.1159/000342909. Epub 2012 Oct 4.
4
Streptolysin-O reversible permeabilisation is an effective method to transfect siRNAs into myeloma cells.链球菌溶血素O可逆性通透化是一种将小干扰RNA转染至骨髓瘤细胞的有效方法。
J Immunol Methods. 2008 Apr 20;333(1-2):147-55. doi: 10.1016/j.jim.2008.01.009. Epub 2008 Feb 20.
5
Small interfering RNA (siRNA) delivery into murine bone marrow-derived dendritic cells by electroporation.通过电穿孔法将小分子干扰RNA(siRNA)导入小鼠骨髓来源的树突状细胞。
J Immunol Methods. 2008 Aug 20;337(1):71-7. doi: 10.1016/j.jim.2008.04.004. Epub 2008 Apr 28.
6
Electroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and Tissues.电穿孔无边界:电刺激在细胞和组织中用于小干扰RNA递送的应用
J Biomol Screen. 2015 Sep;20(8):932-42. doi: 10.1177/1087057115579638. Epub 2015 Apr 7.
7
Gain- and loss-of-function approaches in the chick embryo.鸡胚中的功能获得和功能丧失方法。
Methods Cell Biol. 2008;87:237-56. doi: 10.1016/S0091-679X(08)00212-4.
8
Transfection of siRNAs in multiple myeloma cell lines.在多发性骨髓瘤细胞系中进行小干扰RNA(siRNA)转染。
Methods Mol Biol. 2010;623:299-309. doi: 10.1007/978-1-60761-588-0_19.
9
Molecular therapeutics of cancer by means of electroporation-based transfer of siRNAs and EBV-based expression vectors.通过基于电穿孔的小干扰RNA转移和基于EB病毒的表达载体进行癌症的分子治疗。
Front Biosci (Elite Ed). 2009 Jun 1;1(1):316-31. doi: 10.2741/E31.
10
Optimizing electroporation conditions in primary and other difficult-to-transfect cells.优化原代细胞及其他难转染细胞的电穿孔条件。
J Biomol Tech. 2008 Dec;19(5):328-34.

引用本文的文献

1
Association of ADAM family members with proliferation signaling and disease progression in multiple myeloma.ADAM 家族成员与多发性骨髓瘤中增殖信号和疾病进展的关联。
Blood Cancer J. 2024 Sep 11;14(1):156. doi: 10.1038/s41408-024-01133-4.
2
Functional Investigation of Mutations in Multiple Myeloma.多发性骨髓瘤中突变的功能研究
Cancers (Basel). 2024 Jun 4;16(11):2139. doi: 10.3390/cancers16112139.
3
FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis.

本文引用的文献

1
Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.多发性骨髓瘤的广泛遗传异质性:对靶向治疗的影响。
Cancer Cell. 2014 Jan 13;25(1):91-101. doi: 10.1016/j.ccr.2013.12.015.
2
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.多发性骨髓瘤患者的生存率持续提高:老年患者早期死亡率和结局的变化。
Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25.
3
Myeloma: classification and risk assessment.骨髓瘤:分类和风险评估。
FK506 结合蛋白 11 是一种新型浆细胞特异性抗体折叠催化剂,在特发性肺纤维化中表达增加。
Cells. 2022 Apr 14;11(8):1341. doi: 10.3390/cells11081341.
4
Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines.KRAS基因外显子4突变影响人多发性骨髓瘤细胞系中的MEK/ERK和PI3K/AKT信号通路。
Cancers (Basel). 2020 Feb 16;12(2):455. doi: 10.3390/cancers12020455.
5
Assessment of TP53 lesions for p53 system functionality and drug resistance in multiple myeloma using an isogenic cell line model.采用基因相同细胞系模型评估多发性骨髓瘤中 TP53 损伤对 p53 系统功能和耐药性的影响。
Sci Rep. 2019 Dec 2;9(1):18062. doi: 10.1038/s41598-019-54407-4.
6
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1 subgroup of multiple myeloma cells for TNF-induced cell death.NEDD8-激活酶抑制剂 MLN4924 增敏 TNF 诱导多发性骨髓瘤细胞死亡的 TNFR1 亚群。
Cell Death Dis. 2019 Aug 13;10(8):611. doi: 10.1038/s41419-019-1860-2.
7
GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.GRP78 调节前列腺癌和多发性骨髓瘤细胞系中的细胞黏附标志物。
BMC Cancer. 2018 Dec 18;18(1):1263. doi: 10.1186/s12885-018-5178-8.
8
A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors.使用 Sleeping Beauty 载体的多靶向 shRNA 介导的诱导性敲低的简单方法。
PLoS One. 2018 Oct 19;13(10):e0205585. doi: 10.1371/journal.pone.0205585. eCollection 2018.
9
Ionomycin-Induced Changes in Membrane Potential Alter Electroporation Outcomes in HL-60 Cells.离子霉素诱导的膜电位变化改变 HL-60 细胞的电穿孔效果。
Biophys J. 2018 Jun 19;114(12):2875-2886. doi: 10.1016/j.bpj.2018.05.018.
10
High Efficiency Low Cost Fibroblast Nucleofection for GMP Compatible Cell-based Gene Therapy.高效低成本成纤维细胞转染用于符合 GMP 的基于细胞的基因治疗。
Int J Med Sci. 2017 Jul 19;14(9):798-803. doi: 10.7150/ijms.19241. eCollection 2017.
Semin Oncol. 2013 Oct;40(5):554-66. doi: 10.1053/j.seminoncol.2013.07.002.
4
Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.敲低DEPTOR可通过抑制PI3K/AKT活性来抑制人多发性骨髓瘤RPMI-8226细胞的增殖并增加对美法仑的化疗敏感性。
J Int Med Res. 2013 Jun;41(3):584-95. doi: 10.1177/0300060513480920. Epub 2013 Apr 15.
5
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.欧洲癌症发病率和死亡率模式:2012 年 40 个国家的估计数。
Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.
6
Molecular pathogenesis of multiple myeloma: basic and clinical updates.多发性骨髓瘤的分子发病机制:基础与临床更新。
Int J Hematol. 2013 Mar;97(3):313-23. doi: 10.1007/s12185-013-1291-2. Epub 2013 Feb 28.
7
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
8
Molecular pathogenesis of multiple myeloma and its premalignant precursor.多发性骨髓瘤及其恶性前体的分子发病机制。
J Clin Invest. 2012 Oct;122(10):3456-63. doi: 10.1172/JCI61188. Epub 2012 Oct 1.
9
Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?多发性骨髓瘤的连续 Total Therapy 试验改善了长期结果:患者现在是否被治愈了?
Leukemia. 2013 Jan;27(1):226-32. doi: 10.1038/leu.2012.160. Epub 2012 Jun 18.
10
Integrin-linked kinase is dispensable for multiple myeloma cell survival.整合素连接激酶对于多发性骨髓瘤细胞的存活并非必需。
Leuk Res. 2012 Sep;36(9):1165-71. doi: 10.1016/j.leukres.2012.05.005. Epub 2012 Jun 1.